Anthropometry (3)
- bmi_baseline - Baseline body mass index (BMI) in kg/m2 (phv00190305.v3.p3)
- height_baseline - Standing height in cm. at first participant visit (phv00190310.v3.p3)
- weight_baseline - Weight in kg. at first participant visit (phv00190307.v3.p3)
Biomarkers (32)
- apoa1 - Apolipoprotein A1 measurement in mg/L at designated visit (may not be from first visit) (phv00190341.v3.p3)
- apob - Apolipoprotein B measurement in mg/L at designated visit (may not be from first visit) (phv00190343.v3.p3)
- basophils - Basophils in absolute numbers at designated visit (may not be from first visit) (phv00190377.v3.p3)
- cornell_voltage_ekg - Cornell voltage for EKG measurement (phv00190388.v3.p3)
- crp - C-reactive protein level in mg/L at designated visit (may not be from first visit) (phv00190353.v3.p3)
- dbp_baseline - Diastolic blood pressure (DBP) at first participant visit (avg. of 2 measurements), in mm Hg (phv00190317.v3.p3)
- ekg_hr - HR interval from EKG at designated visit (may not be from first visit) (phv00190385.v3.p3)
- ekg_pr - PR interval from EKG at designated visit (may not be from first visit) (phv00190384.v3.p3)
- ekg_qrs - QRS interval from EKG at designated visit (may not be from first visit) (phv00190382.v3.p3)
- ekg_qt - QT interval from EKG at designated visit (may not be from first visit) (phv00190383.v3.p3)
- eosinophils - Eosinophils in absolute numbers at designated visit (may not be from first visit) (phv00190376.v3.p3)
- factorVII - Factor VII level in % at designated visit (may not be from first visit) (phv00190347.v3.p3)
- factorVIII - Factor VIII level in % at designated visit (may not be from first visit) (phv00190349.v3.p3)
- fibrinogen - Fibrinogen level in mg/dL at first designated visit (may not be from first visit) (phv00190345.v3.p3)
- hdl_baseline - High density lipoprotein (HDL) cholesterol level in mg/dL at first participant visit (phv00190312.v3.p3)
- hematocrit - Hematocrit at designated visit (may not be from first visit) in % (phv00190365.v3.p3)
- hemoglobin - Hemoglobin at designated visit (may not be from first visit) in g/dl (phv00190363.v3.p3)
- icam1 - ICAM1 level in ng/mL at designated visit (may not be from first visit) (phv00190357.v3.p3)
- il6 - IL6 level in pg/mL at designated visit (may not be from first visit) (phv00190355.v3.p3)
- ldl_baseline - Baseline calculated low density lipoprotein (LDL) cholesterol in mg/dL (missing where trigs>400) (phv00190311.v3.p3)
- lymphocytes - Lymphocytes in absolute numbers at designated visit (may not be from first visit) (phv00190375.v3.p3)
- mean_corpuscular_volume - Mean corpuscular volume in femtoliters at designated visit (may not be from first visit) (phv00190367.v3.p3)
- monocytes - Monocytes in absolute numbers at designated visit (may not be from first visit) (phv00190374.v3.p3)
- neutrophils - Neutrophils in absolute numbers at designated visit (may not be from first visit) (phv00190373.v3.p3)
- platelet_count - Platelet count at designated visit (may not be from first visit) in x 1000/cubic mm (phv00190368.v3.p3)
- pselectin - P-selectin level at designated visit (may not be from first visit) (phv00190359.v3.p3)
- red_blood_count - Red blood cell count (RBC) in million cells per microliter at designated visit (may not be from first visit) (phv00190371.v3.p3)
- sbp_baseline - Systolic blood pressure (SBP) at first participant visit (avg. of 2 measurements), in mm Hg (phv00190316.v3.p3)
- totchol_baseline - Total cholesterol level at first participant visit in mg/dL (phv00190314.v3.p3)
- trigs_baseline - Triglyceride level at first participant visit in mg/dL (phv00190313.v3.p3)
- vWF - VWF level in % at designated visit (may not be from first visit) (phv00190351.v3.p3)
- wbc - White blood count in x1,000/cubic mm at designated visit (may not be from first visit) (phv00190361.v3.p3)
Demographics (24)
- age_at_2nd_blood_counts - Age in years at secondary blood count measurements (MCV, RBC, Neutrophils, Monocytes, Lymphocytes, Eosinophils, Basophils) (phv00190378.v3.p3)
- age_at_apoa1 - Age in years at Apolipoprotein A1 measurement (phv00190342.v3.p3)
- age_at_apob - Age in years at Apolipoprotein B measurement (phv00190344.v3.p3)
- age_at_crp - Age in years at CRP measurement (phv00190354.v3.p3)
- age_at_ekg - Age in years at EKG visit (phv00190389.v3.p3)
- age_at_factorVII - Age in years at Factor VII measurement (phv00190348.v3.p3)
- age_at_factorVIII - Age in years at Factor VIII measurement (phv00190350.v3.p3)
- age_at_fasting_glucose - Age at fasting glucose (phv00190340.v3.p3)
- age_at_fasting_insulin - Age at fasting insulin (phv00190338.v3.p3)
- age_at_fibrinogen - Age in years at Fibrinogen measurement (phv00190346.v3.p3)
- age_at_hematocrit - Age in years at hematocrit measurement (phv00190366.v3.p3)
- age_at_hemoglobin - Age in years at hemoglobin measurement (phv00190364.v3.p3)
- age_at_icam1 - Age in years at ICAM1 measurement (phv00190358.v3.p3)
- age_at_il6 - Age in years at IL6 measurement (phv00190356.v3.p3)
- age_at_imt - Age in years at intima media thickness (IMT) measurement (phv00190381.v3.p3)
- age_at_mcv - Agein years at mean corpuscular volume measurement (phv00190370.v3.p3)
- age_at_platelet_count - Age in years at platelet count measurement (phv00190369.v3.p3)
- age_at_pselectin - Age in years at P-selectin measurement (phv00190360.v3.p3)
- age_at_rbc - Age in years at red blood cell count measurement (phv00190372.v3.p3)
- age_at_vWF - Age in years at visit of hemostatic factors measurement (phv00190352.v3.p3)
- age_at_wbc - Age in years at WBC measurement (phv00190362.v3.p3)
- age_baseline - Age in years at first participant visit (phv00190304.v3.p3)
- age_lung_function - Age in years at lung function (FEV1 and FVC) measurements (phv00190392.v3.p3)
- sex_selfreport - Values: Male; Female (phv00190302.v3.p3)
Disease Events (4)
- angioplasty_baseline - History of angioplasty at first visit (0/1) (phv00190320.v3.p3)
- cabg_baseline - History of coronary artery bypass (CABG) at first visit (0/1) (phv00190321.v3.p3)
- mi_baseline - History of myocardial infarction (MI) recorded at first participant visit (0/1). (phv00190322.v3.p3)
- t2diabetes_baseline - Type 2 diabetes (T2D) status at first participant visit (0/1) (phv00190306.v3.p3)
Geography (1)
- study_site - Study site, field clinic, or center within study (phv00190303.v3.p3)
Imaging (1)
- imt_meanmean_farwall_cca - Average far wall thickness of the right and left common carotid mean intima media thickness (IMT) values, using as many views as are available for a given study (phv00190379.v3.p3)
Medications (2)
- htn_med_baseline - Hypertension med status (any) at first participant visit (0/1) (phv00190319.v3.p3)
- lipid_med_baseline - Any lipid lowering medication (statin or other) at first participant visit (phv00190315.v3.p3)
Race and Ethnicity (1)
- race_selfreport - Self report race (phv00190301.v3.p3)
Reproductive Health (1)
- age_at_menarche - Age in years at menarche (start of menstruation) (phv00190336.v3.p3)
Respiratory (2)
- fev1_first_avail_visit - Forced expiratory volume (FEV1) measurement at the first available visit (phv00190390.v3.p3)
- fvc_first_avail_visit - Forced vital capacity (FVC) measurement at the first available visit (phv00190391.v3.p3)
Substance Use (2)
- current_smoker_baseline - Current smoking status at first participant visit (0/1) (phv00190334.v3.p3)
- former_smoker_baseline - Former smoking status at first participant visit (0/1) (phv00190335.v3.p3)
Other (24)
- afib_baseline - History of atrial fibrillation at first participant visit (0/1) (phv00190329.v3.p3)
- afib_during_followup - 0/1 to indicate that an atrial fibrillation occurred during study follow up. 0 if no afib during study follow up. 1 if an adjudicated afib occurred during study follow up. (phv00190330.v3.p3)
- afib_tte_or_censor - Time to event variable for atrial fibrillation. Time (in days) from start of study to afib for event that occurred during study follow up; and follow up time for those that did not have an afib during study follow up (phv00190331.v3.p3)
- ANALYTE_TYPE - Analyte type (phv00190395.v3.p3)
- BODY_SITE - Body site where sample was collected (phv00190394.v3.p3)
- chf_baseline - History of congestive heart failure (CHF) at first participant visit (phv00190328.v3.p3)
- death - 0/1 to indicate that the participant died during study follow up (phv00190332.v3.p3)
- death_tte_or_censor - Time to death or censoring time. Time (in days) from start of study to death for participants that died during study follow up; and follow up time for those that did not die during study follow up (phv00190333.v3.p3)
- fasting_glucose - Blood fasting glucose at first participant visit in mg/dL (phv00190339.v3.p3)
- fasting_insulin - Blood fasting insulin at first participant visit in uU/mL. (Note that there are some extreme outliers) (phv00190337.v3.p3)
- htn_status_baseline - Hypertension status at first participant visit (0/1) (phv00190318.v3.p3)
- imt_meanmean_farwall_ica - Average far wall thickness of the right and left internal carotid maximum intima media thickness IMT values, using as many views as are available for a given study (phv00190380.v3.p3)
- IS_TUMOR - Tumor status (phv00190396.v3.p3)
- lvh_at_ekg - Left ventriculat hypertrophy status at first participant visit (0/1) (phv00190386.v3.p3)
- mi_during_followup - 0/1 to indicate that a myocardial infarction (MI) occurred during study follow up. 0 if no MI during study follow up. 1 if an adjudicated MI occurred during study follow up (even if baseline MI status was 1). (phv00190323.v3.p3)
- mi_tte_or_censor - Time to event variable for myocardial infarction (MI). Time (in days) from start of study to MI for event that occurred during study follow up; and follow up time for those that did not have an MI during study follow up. (phv00190324.v3.p3)
- SAMPLE_ID - De-identified sample ID (phv00190393.v4.p3)
- stroke_baseline - History of stroke at first participant visit (0/1) (phv00190325.v3.p3)
- stroke_during_followup - 0/1 to indicate that a stroke occurred during study follow up. 0 if no stroke during study follow up. 1 if an adjudicated stroke occurred during study follow up. (phv00190326.v3.p3)
- stroke_tte_or_censor - Time to event variable for stroke. Time (in days) from start of study to stroke for event that occurred during study follow up; and follow up time for those that did not have an adjudicated stroke during study follow up. (phv00190327.v3.p3)
- SUBJECT_ID - Participant ID submitted to dbGaP (phv00190300.v4.p3)
- waist_baseline - Waist in cm. at first participant visit (phv00190308.v3.p3)
- whr_baseline - Waist to hip ratio at first participant visit (phv00190309.v3.p3)
- wpw_or_avblock2_at_ekg - Indicator (0/1) for Wolff-Parkinson-White pattern or second degree AV Block at EKG visit (phv00190387.v3.p3)